Non-Negative Drug Tests Don’t Mean Pilot Drug Use: ALPAI Chief
By Business Desk
ALPAI Chief Sam Thomas explains non-negative drug tests for pilots don’t confirm drug use, highlighting common medications as potential false positives.
Captain Sam Thomas, president of the Airline Pilots’ Association of India (ALPAI), has clarified that an initial “non-negative” dope test result for pilots does not automatically indicate drug use. This statement follows the Air India Phuket-Delhi incident, where pilots were subject to drug testing.
Understanding Non-Negative Test Results
Thomas emphasized that several common substances can trigger false positives in drug screenings. These include readily available over-the-counter medications and certain supplements.
- Common over-the-counter medications
- Antihistamines for colds
- Protein supplements
- Bodybuilding products
ALPAI advises pilots to completely avoid self-medication. Furthermore, they should disclose all prescribed medications to their company doctors to prevent potential issues.
The Role of Confirmatory Testing
The ALPAI president stressed the critical need for confirmatory testing after any non-negative screening. This step is essential to ensure accuracy before reaching conclusions that could significantly impact a pilot’s professional career.
He underscored that such tests are vital for a fair assessment of the situation. Without confirmation, initial results could lead to unwarranted career consequences.
Technical Investigation into the Incident
Thomas also clarified that the drug testing matter is distinct from the technical investigation into the Airbus A320 aircraft incident. The plane lost approximately 300 feet of altitude, resulting in injuries to 17 people.
Pilot and engineering reports indicate a technical fault affected all three hydraulic systems of the aircraft. This malfunction led to an autopilot disconnection and a subsequent stall warning, prompting the co-pilot to take corrective action.
India’s Aircraft Accident Investigation Bureau is leading the inquiry, with participation from Airbus and France’s BEA. The investigation will meticulously cross-reference pilot reports with flight data recorder information to determine the cause.
Captain Thomas urged against prematurely linking the incident to medication or substance use. He maintained that conclusions should await the completion of all confirmatory tests and the full technical investigation.